Is intraperitoneal dextran 70 safe for routine gynecologic use?

Area of Science:

• Gynecology
• Surgical Adhesion Prevention
• Pharmacology

Background:

• Postsurgical pelvic adhesions are a common complication following gynecologic operations.
• Intraperitoneal 32% dextran 70 is a potential adjuvant therapy to prevent adhesion formation.

Purpose of the Study:

• To evaluate the safety and tolerability of an antiadhesion regimen using intraperitoneal 32% dextran 70, dexamethasone, and promethazine.
• To assess the efficacy of this regimen in preventing postsurgical pelvic adhesions.

Main Methods:

• A prospective study involving 234 women undergoing gynecologic operations.
• Administration of an antiadhesion regimen including intraperitoneal 32% dextran 70, dexamethasone, and promethazine.

Main Results:

• Four percent (10/234) of women experienced spontaneous leakage of the dextran-peritoneal fluid mixture.
• Eight percent (18/234) reported painless bilateral labial swelling.
• Mild abdominal bloating and weight gain were common; no anaphylactic reactions, peritonitis, or wound infections occurred.

Conclusions:

• Intraperitoneal dextran 70, as part of a multi-agent regimen, appears safe and well-tolerated for preventing pelvic adhesions.
• The observed side effects were generally mild and did not lead to serious complications.
• This regimen shows promise for routine use in gynecologic surgery to reduce adhesion formation.